Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 33

Trial Status

Completed3
Terminated2

Role Distribution

Principal Investigator1
Other Roles4
PI Rate20%

Activity Timeline

Research Network

Collaboration Network

19 collaborators·51 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Lymphoma Study Association

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Roberto Hernández Martín, MD

Hospital Virgen de la Concha

Moderately Similar
2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, Mantle-Cell
Similarity Score30%

Elena Pérez Ceballos, MD

Hospital Morales Meseguer

Moderately Similar
2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, Mantle-Cell
Similarity Score30%

Carlos Montalbán Sanz, MD

Hospital Universitario Ramon y Cajal

Moderately Similar
2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, Mantle-Cell
Similarity Score30%

Eulogio Conde García, MD

Hospital Marqués de Valdecilla

Moderately Similar
2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, Mantle-Cell
Similarity Score30%

Brenda Sandmaier

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Moderately Similar
12 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, Mantle-Cell
Similarity Score30%

William Wegener, MD, PhD

Gilead Sciences

Moderately Similar
12 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, Mantle-Cell
Similarity Score30%

Miguel Ángel Canales Albendea, MD

Hospital La Paz

Moderately Similar
2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, Mantle-Cell
Similarity Score30%

Richard Delarue, MD

Lymphoma Study Association

Related
2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, Mantle-Cell

Worked with same sponsors:

AmgenLymphoma Study Association
Collaborated on 2 trials
Similarity Score28%

Corinne Haioun, MD

Lymphoma Study Association

Related
4 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse

Worked with same sponsors:

AmgenLymphoma Study Association
Collaborated on 4 trials
Similarity Score26%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse

Worked with same sponsors:

Amgen
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT00847223Phase 2PrincipalInvestigator

Efficacy and Safety of the Farnesyl-transferase Inhibitor (Tipifarnib) in Mantle Cell Lymphoma

Mantle Cell Lymphoma
Terminated
NCT00140660Phase 3StudyChair

ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell Lymphoma

Diffuse Large Cell Lymphoma
Terminated
NCT00140595Phase 3StudyChair

ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1

Diffuse Large-Cell Lymphoma
Completed
NCT00144755Phase 3StudyChair

R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma

Diffuse Large Cell Lymphoma
Completed
NCT00144807Phase 2StudyChair

ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma

Diffuse Large Cell Lymphoma
Completed

All 5 trials loaded